Financial PerformanceDH reported solid 3Q:24 results with revenue and adjusted EBITDA exceeding consensus estimates.
Market Position And StrategyDefinitive Healthcare is one of the healthcare industry's most comprehensive data collection and analytics platforms that supports bio-pharma, life sciences, health systems, med-tech, and the broad healthcare eco-system.
Stock Repurchase ProgramDefinitive was able to re-up its buyback authorization, adding $100M to its previously announced $20M repurchase program, which the firm plans to execute against over the course of 2025 to take advantage of what’s clearly an inexpensive stock.